IL1A and chronic obstructive pulmonary disease: In an exploratory study in COPD patients, levels of IL-1α and β recovered from the sputum of COPD patients were significantly correlated (p<0.0001) during stable disease, at the onset of exacerbation (prior to additional treatment), and 7 and 35 days post-exacerbation (Figure 1F–I).